StefanCharlesGrantMD

PubMed

• 1 citations
  Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations.
  Thomas J George, Tara L Lin, Tricia Adrales Bentz, Stefan Grant, Collette M Houston, Melissa A Nashawati, Bhanu Pappu, Helen Peck, Alex Zafirovski, Kimberly Kerstann, ...> ;JNCI Cancer Spectrum. 2023 Jul 3
• Team-Based Hospice Referrals: A Potential Quality Metric for Lung Cancer in the Immunotherapy Era.
  Thomas W Lycan Jr, Alyssa Buckenheimer, Jimmy Ruiz, Gregory Russell, Andy Shipe Dothard, Tamjeed Ahmed, Stefan Grant, Carl Grey, William J Petty> ;The American Journal of Hospice & Palliative Care. 2023 Jan 1
• 6 citations
  A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
  Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, Shuli Li, Ilana F Gareen, Keith T Flaherty, Benjamin A Herman, Susan M Domchek, Angela M DeMichele, Kara N Maxwel...> ;Cancer. 2022 Apr 1
• 7 citations
  Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer.
  Rhonda L. Bitting, Janet A. Tooze, Scott Isom, W. Jeffrey Petty, Stefan C. Grant, Rodwige J. Desnoyers, Alexandra Thomas, Christopher Y. Thomas, Angela Tatiana Alistar...> ;American Journal of Clinical Oncology. 2021 Jun 1
• 11 citations
  Informed Consent-We Can and Should Do Better.
  Stefan C. Grant> ;JAMA Network Open. 2021 Apr 1
• 12 citations
  Unmet Care Needs and Financial Hardship in Patients With Metastatic Non–Small-Cell Lung Cancer on Immunotherapy or Chemoimmunotherapy in Clinical Practice
  Laurie E. McLouth, Chandylen L Nightingale, Beverly J. Levine, Jessica L. Burris, Jean A. McDougall, Thomas Lycan, Jennifer Gabbard, Jimmy Ruiz, Michael Farris, Arthur...> ;JCO Oncology Practice. 2021 Feb 4
• 5 citations
  Clinical Trial Metrics: The Complexity of Conducting Clinical Trials in North American Cancer Centers.
  Carrie B. Lee, Theresa L. Werner, Allison M. Deal, Cassandra J Krise-Confair, Tricia A. Bentz, Theresa M Cummings, Stefan C. Grant, Ashley Baker Lee, Jessica Moehle, K...> ;JCO Oncology Practice. 2021 Jan 1
• 25 citations
  SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis
  Liang Liu, Tamjeed Ahmed, William J. Petty, Stefan C. Grant, Jimmy Ruiz, Thomas Lycan, Umit Topaloglu, Ping Chieh Chou, Lance D. Miller, Gregory A. Hawkins, Martha A. ...> ;Molecular Oncology. 2021 Feb 1
• 27 citations
  Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.
  Laurie E. McLouth, Thomas Lycan, Beverly J. Levine, Jennifer Gabbard, Jimmy Ruiz, Michael Farris, Stefan C. Grant, Nicholas M. Pajewski, Kathryn E. Weaver, W. Jeffrey ...> ;Clinical Lung Cancer. 2020 May 1
• 17 citations
  Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer
  Tamjeed Ahmed, Thomas Lycan, Andy Dothard, Paul Ehrlichman, Jimmy Ruiz, Michael Farris, Umit Topaloglu, Beverly J. Levine, Stefan C. Grant, Heidi D. Klepin, W. Jeffrey...> ;Clinical Lung Cancer. 2020 Jul 1
• 27 citations
  Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.
  Marcelo Bonomi, Tamjeed Ahmed, Safoa Addo, Mitra Kooshki, Dario Palmieri, Beverly J. Levine, Jimmy Ruiz, Stefan C. Grant, William J. Petty, Pierre L. Triozzi> ;Oncology Letters. 2018 Nov 19
• 51 citations
  Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.
  David S. Hong, Kathleen N. Moore, Manish R. Patel, Stefan C. Grant, Howard A. Burris, William N. William, Suzanne F. Jones, Funda Meric-Bernstam, Jeffrey R. Infante, L...> ;Clinical Cancer Research. 2018 Apr 11
• 27 citations
  Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
  Ahmed Ashour Badawy, Gehan A Khedr, Abbas Omar, Sejong Bae, Waleed Arafat, Stefan C. Grant> ;Asian Pacific Journal of Cancer Prevention. 2018 Jul 27
• 23 citations
  Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
  Liang Liu, Jimmy Ruiz, Stacey S O'Neill, Stefan C. Grant, W. Jeffrey Petty, Meng Yang, Kexin Chen, Umit Topaloglu, Boris Pasche, Wei Zhang> ;Molecular Cancer. 2018 Apr 12
• 63 citations
  Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?
  M. Yang, M. E. Forbes, Rhonda L. Bitting, Stacey S O'Neill, Ping Chieh Chou, Umit Topaloglu, Lance D. Miller, Gregory A. Hawkins, Stefan C. Grant, Barry DeYoung, Willi...> ;Annals of Oncology. 2018 Feb 1
• 28 citations
  Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages
  Meng Yang, Umit Topaloglu, W. Jeffrey Petty, Matthew Pagni, Kristie L. Foley, Stefan C. Grant, Mac B. Robinson, Rhonda L. Bitting, Alexandra Thomas, Angela Tatiana Ali...> ;Journal of Hematology & Oncology. 2017 May 4
• 27 citations
  Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.
  Ville Kytölä, Umit Topaloglu, Lance D. Miller, Rhonda L. Bitting, Michael Goodman, Ralph D’ Agostino, Rodwige J. Desnoyers, Carol A. Albright, George Yacoub, Shadi Qas...> ;Theranostics. 2017 Jul 12
• 60 citations
  Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment
  Cara C. Schafer, Yong Wang, Kenneth P. Hough, Anandi Sawant, Stefan C. Grant, Victor J. Thannickal, Jaroslaw W. Zmijewski, Selvarangan Ponnazhagan, Jessy S. Deshane> ;Oncotarget. 2016 Sep 26
• 1 citations
  Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small ce...
  Daniel Joseph Allendorf, Rodolfo Bordoni, Stefan C. Grant, Mansoor N. Saleh, Vishnu Reddy, Mary Jerome, Pamela M. Dixon, Deborah Miley, Karan P. Singh, Francisco Robert> ;Cancer Chemotherapy and Pharmacology. 2015 Sep 22
• A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations.
  Zhou L, Zhang Y, Chen S, Kmieciak M, Leng Y, Lin H, Rizzo KA, Dumur CI, Ferreira-Gonzalez A, Dai Y, Grant S> ;Leukemia. 2015-04-01
• 24 citations
  Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
  Boris Pasche, Stefan C. Grant> ;JAMA. 2014 May 21
• 66 citations
  Enhancement of Antitumor Immunity in Lung Cancer by Targeting Myeloid-Derived Suppressor Cell Pathways
  Anandi Sawant, Cara C. Schafer, Tong Huan Jin, Jaroslaw W. Zmijewski, Hubert M. Tse, Justin C. Roth, Zhihuan Sun, Gene P. Siegal, Victor J. Thannickal, Stefan C. Grant...> ;Cancer Research. 2013 Nov 15
• 313 citations
  Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines
  David S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Ramaswamy Govindan, Fre...> ;Journal of the National Comprehensive Cancer Network. 2013 Jun 1
• 55 citations
  Thymomas and thymic carcinomas
  David S. Ettinger, Gregory J. Riely, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Ramas...> ;Journal of the National Comprehensive Cancer Network. 2013 May 1
• Phase I trial of vorinostat plus bortezomib (bort) in relapsed/refractory multiple myeloma (mm) patients (pts).
  Badros AZ, Philip S, Niesvizk R, Goloubeva O, Harris C, Zweibel J, Wright JJ, Burger A, Baer MR, Egorin MJ, Grant S> ;J. Clin. Oncol.. 2008-05-20
• Join now to see all